Multi-pathogen nucleic acid detection device

By designing a multi-pathogenic nucleic acid detection device, the reaction liquid and DNA eluent are automatically distributed using liquid flow pipelines, combined with the use of OTG dyes, the problem of complex and high cost in the detection process in the existing technology is solved, and the multi-efficiency and low cost are achieved Pathogen nucleic acid detection, suitable for field applications.

CN222007789UActive Publication Date: 2024-11-15TECON BIOPHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202323495101.4
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-12-21
Publication Date
2024-11-15
Estimated Expiration
2033-12-21

AI Technical Summary

Technical Problem

The existing pathogenic nucleic acid detection methods have problems such as complex detection process, high experimental requirements, high cost and cumbersome operation, and are especially not suitable for field testing.

Method used

A multi-pathogenic nucleic acid detection device was designed, using a liquid flow pipeline to automatically distribute the reaction liquid and DNA eluent, simplifying the operation steps, including independent reaction units and OTG dyes, realizing the integration of mixing, amplification and result analysis, reducing the Artificial error and consumable costs.

Benefits of technology

It greatly simplifies the operation steps, reduces artificial errors and consumable costs, realizes one-time detection of multiple pathogens, avoids the pollution problems during primer interference and liquid mixing, improves the reaction efficiency and reagent use efficiency, and is suitable for field testing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222007789U_ABST
    Figure CN222007789U_ABST
Patent Text Reader

Abstract

The utility model discloses a multi-pathogen nucleic acid detection device which comprises a liquid flow pipeline used for receiving mixed reaction liquid of reaction liquid and DNA (deoxyribonucleic acid) eluent; each reaction unit comprises a reaction tube and a primer cavity, the primer cavity is used for introducing a corresponding primer, one end of the reaction tube is selectively communicated to the primer cavity in an on-off manner so as to receive the corresponding primer from the primer cavity when the reaction tube is communicated, and the other end of the reaction tube is communicated with the primer cavity. And the other end of the reaction pipe is selectively communicated to the liquid flow pipeline in an on-off manner so as to receive the mixed reaction liquid from the liquid flow pipeline during communication. According to the multi-pathogen nucleic acid detection device, under the gravity and negative pressure environment, the mixed reaction liquid of the reaction liquid and the DNA eluent is automatically distributed into each reaction tube through the liquid flow pipeline, and compared with the prior art that the mixed reaction liquid is added into test tubes one by one, the operation steps are greatly simplified, and the personal error and the consumable cost are reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to a nucleic acid detection device, in particular to a multi-pathogen nucleic acid detection device. Background Art

[0002] Currently, pathogen nucleic acid detection mainly relies on two main methods: polymerase chain reaction (PCR) and real-time fluorescence quantitative PCR (PCR). However, these methods have the characteristics of complex detection process, high experimental environment requirements, high personnel requirements, high detection cost, and expensive instruments and equipment.

[0003] The Chinese invention patent application with publication number CN115612752A provides a method and kit for detecting SARS-CoV-2 based on loop-mediated isothermal amplification. The kit of the prior art is a test tube type, so although the loop-mediated isothermal amplification technology has the characteristics of simple equipment requirements and low personnel requirements, it still has the disadvantages of cumbersome operation and high cost, which is not conducive to field detection. Utility Model Content

[0004] Purpose of the utility model: The technical problem to be solved by the utility model is to provide a multi-pathogen nucleic acid detection device in response to the deficiencies in the prior art, which greatly simplifies the operating steps and reduces human errors and consumables costs.

[0005] In order to solve the above technical problems, the utility model discloses a multi-pathogen nucleic acid detection device, which comprises:

[0006] A liquid flow pipeline, the liquid flow pipeline is used to receive a mixed reaction solution of a reaction solution and a DNA elution solution;

[0007] And more than one reaction unit, each reaction unit includes a reaction tube and a primer chamber, the primer chamber is used to introduce corresponding primers, one end of the reaction tube can be selectively connected to the primer chamber to receive the corresponding primer from the primer chamber when connected, and the other end of the reaction tube can be selectively connected to the liquid flow pipeline to receive the mixed reaction liquid from the liquid flow pipeline when connected.

[0008] The multi-pathogen nucleic acid detection device of the present application automatically distributes the mixed reaction solution of the reaction solution and the DNA elution solution into each reaction tube through the liquid flow pipeline under gravity and negative pressure environment. Compared with adding them into the test tubes one by one in the prior art, the device of the present application greatly simplifies the operation steps and reduces human errors and consumables costs.

[0009] At the same time, the multi-pathogen nucleic acid detection device of the present application can realize one-time detection of multiple pathogens, and each pathogen corresponds to an independent reaction unit, each independent reaction unit includes an independent primer chamber and a corresponding reaction tube, avoiding interference between primers.

[0010] Furthermore, the detection device also includes a liquid adding chamber, a nucleic acid adding chamber and a mixing chamber; the liquid adding chamber is used to accommodate a reaction liquid; the nucleic acid adding chamber is used to accommodate a DNA eluent; the liquid adding chamber and the nucleic acid adding chamber can be selectively connected to the inlet side of the mixing chamber, and the liquid flow pipeline can be selectively connected to the outlet side of the mixing chamber; the mixing chamber is configured to mix the reaction liquid and the DNA eluent, and to provide a mixed reaction liquid to the liquid flow pipeline.

[0011] The multi-pathogen nucleic acid detection device of this embodiment is provided with a liquid adding chamber, a nucleic acid adding chamber and a mixing chamber, so that mixing, amplification and result analysis are integrated. Compared with the utility model in which some operations can be performed in a well plate or a centrifuge tube, the present application avoids the problems of aerosol generation during liquid mixing, operational pollution, large reaction volume and liquid evaporation due to lax sealing.

[0012] Furthermore, the detection device also includes an OTG dye and a light-transmitting area, wherein the OTG dye is pre-placed at the top of the inner cavity of the reaction tube, the light-transmitting area corresponds to the area where the reaction tube is located, and the light-transmitting area is configured to allow ultraviolet light to pass through.

[0013] The multi-pathogen nucleic acid detection device of this embodiment is provided with OTG dye and light-transmitting area. The OTG dye is used as a color indicator to help quickly judge the experimental results. It also omits the gel electrophoresis step in the existing nucleic acid detection method, which not only reduces the amount of reagents used, improves the reaction efficiency, but also reduces the cost of reagent use.

[0014] Furthermore, the detection device also includes a waste liquid collection chamber and a liquid discharge port. The waste liquid collection chamber can be selectively connected to the liquid flow pipeline in an on-off manner, and is used to collect mixed reaction liquid exceeding the reaction tube when connected; the liquid discharge port can be selectively connected to the waste liquid collection chamber in an on-off manner, and is used to discharge the liquid in the waste liquid collection chamber when connected.

[0015] Specifically, the detection device includes a second upstream control valve and a second downstream control valve, one end of the reaction tube is connected to the primer chamber through the second downstream control valve, and the other end of the reaction tube is connected to the liquid flow pipeline through the second upstream control valve.

[0016] Specifically, the detection device includes a sample loading microfluidic channel, a first upstream control valve and a first downstream control valve. The liquid loading chamber and the nucleic acid loading chamber are respectively connected to the inlet side fluid of the mixing chamber through a corresponding sample loading microfluidic channel; each of the sample loading microfluidic channels is respectively provided with a first upstream control valve, and the first upstream control valve is configured to control the on-off of the sample loading microfluidic channel in which it is located; the first downstream control valve is configured to selectively cut off the flow of the fluid in the mixing chamber to the liquid flow pipeline.

[0017] The multi-pathogen nucleic acid detection device of this embodiment adopts loop-mediated isothermal amplification, and the entire operation process is connected and controllable step by step, which greatly reduces the requirements for experimental facilities, equipment and personnel, and is efficient, low-cost and practical.

[0018] Specifically, the detection device includes a third upstream control valve and a third downstream control valve, the waste liquid collection chamber is connected to the liquid flow pipeline through the third upstream control valve, and the drain port is connected to the waste liquid collection chamber through the third downstream control valve.

[0019] Specifically, the detection device has a split structure and includes a base layer and a cover layer covering the upper side of the base layer. The liquid adding chamber, nucleic acid adding chamber, mixing chamber, liquid flow pipeline, primer chambers, reaction tubes and control valves are respectively arranged on the base layer.

[0020] Specifically, the cover plate layer is provided with an observation window for observing the reaction tube and a shielding area outside the observation window, and the observation window corresponds to the area of ​​the cover plate layer above the reaction tube.

[0021] Specifically, the cover layer is provided with a liquid adding hole, a nucleic acid adding hole and a primer hole. The position of the liquid adding hole corresponds to the position of the liquid adding cavity and leads to the liquid adding cavity; the position of the nucleic acid adding hole corresponds to the position of the nucleic acid adding cavity and leads to the nucleic acid adding cavity; the position of each primer cavity is correspondingly provided with a primer hole, and the primer hole leads to the corresponding primer cavity.

[0022] Beneficial effects:

[0023] (1) The multi-pathogen nucleic acid detection device of the present application automatically distributes the mixed reaction solution of the reaction solution and the DNA elution solution into each reaction tube through a liquid flow pipeline under gravity and negative pressure environment. Compared with the prior art of adding the mixed reaction solution into the test tubes one by one, the device of this embodiment greatly simplifies the operation steps and reduces human errors and consumables costs.

[0024] (2) The multi-pathogen nucleic acid detection device of the present application can realize one-time detection of multiple pathogens, and each pathogen corresponds to an independent reaction unit. Each independent reaction unit includes an independent primer chamber and a corresponding reaction tube, thereby avoiding interference between primers.

[0025] (3) An embodiment of the present application is provided with an OTG dye and a light-transmitting area. The OTG dye serves as a color indicator. The color change after the OTG dye combines with the reaction product helps to quickly judge the experimental results. The gel electrophoresis step in the existing nucleic acid detection method can be omitted, which not only reduces the amount of reagents used, improves the reaction efficiency, but also reduces the cost of reagent use.

[0026] (4) An embodiment of the present application is provided with a liquid adding chamber, a nucleic acid adding chamber and a mixing chamber, so that mixing, amplification and result analysis are integrated. Compared with the present invention in which some operations can be performed in a well plate or a centrifuge tube, the present application avoids the problems of aerosol generation during liquid mixing, operational pollution, large reaction volume and liquid evaporation due to loose sealing.

[0027] (5) A multi-pathogen nucleic acid detection device provided in one embodiment of the present application adopts loop-mediated isothermal amplification, and the entire operation process is connected and controllable step by step, which greatly reduces the requirements for experimental facilities, equipment, personnel, and sterile environment. It is efficient, low-cost, practical, and conducive to field detection. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific implementation methods, and the above and / or other advantages of the present invention will become more clear.

[0029] Figure 1 A schematic perspective view of a multi-pathogen nucleic acid detection device provided by the utility model;

[0030] Figure 2 A schematic diagram of the appearance of a multi-pathogen nucleic acid detection device provided by one embodiment of the utility model;

[0031] Figure 3 A top view of a substrate layer in a multi-pathogen nucleic acid detection device provided in one embodiment of the utility model;

[0032] Figure 4 A top view of a cover layer in a multi-pathogen nucleic acid detection device provided in one embodiment of the utility model.

[0033] The reference numerals in the accompanying drawings are as follows: base layer 1; liquid adding chamber 2; nucleic acid adding chamber 3; mixing chamber 4; light-transmitting area 5; waste liquid collection chamber 6; primer chamber 7; liquid discharge port 8; primer hole 9; sample adding microfluidic channel 12; first upstream control valve 13-1; first downstream control valve 13-3; second upstream control valve 13-4; second downstream control valve 13-5; third upstream control valve 13-6; third downstream control valve 13-7; liquid flow pipeline 14; reaction tube 15; cover layer 16; observation window 17; FTA blood collection card 18; liquid adding hole 19 and nucleic acid adding hole 20. DETAILED DESCRIPTION

[0034] In the present application, the proximal end refers to an end closer to the fluid flow conduit 14 , and the distal end refers to an end farther from the fluid flow conduit 14 .

[0035] Example 1

[0036] See now Figure 1 and Figure 3 The multi-pathogen nucleic acid detection device provided by the utility model includes a liquid flow pipeline 14 and one or more reaction units. Among them, the liquid flow pipeline 14 is used to receive a mixed reaction liquid of a reaction liquid and a DNA eluent. Each reaction unit includes a reaction tube 15 and a primer chamber 7. The primer chamber 7 is used to introduce a corresponding primer. One end of the reaction tube 15 can be selectively connected to the primer chamber 7 in an on-off manner to receive the corresponding primer from the primer chamber 7 when connected. The other end of the reaction tube 15 can be selectively connected to the liquid flow pipeline 14 in an on-off manner to receive the mixed reaction liquid from the liquid flow pipeline 14 when connected. It should be understood that although Figure 1 Six reaction units are shown, but this is merely exemplary and not restrictive. The multi-pathogen nucleic acid detection device may include one, two or more reaction units according to specific needs.

[0037] Specifically, see now Figure 1 and Figure 3 The liquid flow pipe 14 and each reaction tube 15 are located in the same plane and each reaction tube 15 is vertically arranged with respect to the liquid flow pipe 14. A groove of a certain volume is provided at the bottom of each reaction tube 15 to facilitate the reaction.

[0038] Specifically, see now Figure 1 and Figure 3 The above-mentioned device includes a second upstream control valve 13-4 and a second downstream control valve 13-5. One end of the reaction tube 15 is connected to the primer chamber 7 through the second downstream control valve 13-5, and the other end of the reaction tube 15 is connected to the liquid flow pipeline 14 through the second upstream control valve 13-4.

[0039] Example 2

[0040] See now Figure 1 and Figure 3Compared with Example 1, the device provided in the second embodiment of the present application also includes an OTG dye and a light-transmitting area 5. The OTG dye is pre-placed at the top of the inner cavity of the reaction tube 15. The light-transmitting area 5 corresponds to the area where the reaction tube 15 is located, and the light-transmitting area 5 is configured to allow ultraviolet light to pass through.

[0041] Example 3

[0042] See now Figure 1 and Figure 3 Compared with Example 2, the device provided in the third embodiment of the present application further includes a liquid adding chamber 2, a nucleic acid adding chamber 3 and a mixing chamber 4. The liquid adding chamber 2 is used to contain a reaction solution. The nucleic acid adding chamber 3 is used to contain a DNA eluent. The liquid adding chamber 2 and the nucleic acid adding chamber 3 can be selectively connected to the inlet side of the mixing chamber 4 in an on-off manner, and the liquid flow conduit 14 can be selectively connected to the outlet side of the mixing chamber 4 in an on-off manner. The mixing chamber 4 is configured to mix the reaction solution and the DNA eluent, and to provide the mixed reaction solution to the liquid flow conduit 14.

[0043] See now Figure 1 and Figure 3 Specifically, any one of the above-mentioned devices includes a sample loading microfluidic channel 12, a first upstream control valve 13-1 and a first downstream control valve 13-3, and the liquid loading chamber 2 and the nucleic acid loading chamber 3 are respectively connected to the inlet side fluid of the mixing chamber 4 through a corresponding sample loading microfluidic channel 12; each of the sample loading microfluidic channels 12 is respectively provided with a first upstream control valve 13-1, and the first upstream control valve 13-1 is configured to control the on-off of the sample loading microfluidic channel 12 where it is located; the first downstream control valve 13-3 is configured to selectively cut off the flow of the fluid in the mixing chamber 4 to the liquid flow pipeline 14.

[0044] Example 4

[0045] See now Figure 3 Compared with Example 3, the device provided in the fourth embodiment of the present application further includes an FTA blood collection card 18, and the FTA blood collection card 18 is removably disposed in the nucleic acid loading chamber 3.

[0046] Example 5

[0047] See now Figure 1 and Figure 3 Different from the above-mentioned embodiments, the device provided in the fifth embodiment of the present application further includes a waste liquid collection chamber 6 and a liquid discharge port 8. The waste liquid collection chamber 6 can be selectively connected to the liquid flow pipe 14 to collect more mixed reaction liquid than the reaction tube 15 when connected. The liquid discharge port 8 can be selectively connected to the waste liquid collection chamber 6 to discharge the liquid in the waste liquid collection chamber 6 when connected. Now referring to Figure 1 and Figure 3Specifically, the detection device includes a third upstream control valve 13-6 and a third downstream control valve 13-7. The waste liquid collection chamber 6 is connected to the liquid flow pipeline 14 through the third upstream control valve 13-6, and the discharge port 8 is connected to the waste liquid collection chamber 6 through the third downstream control valve 13-7.

[0048] See now Figure 2 The detection device may have a split structure and include a base layer 1 and a cover layer 16 covering the upper side of the base layer 1. Figure 3 The liquid adding chamber 2, the nucleic acid adding chamber 3, the mixing chamber 4, the liquid flow pipeline 14, each primer chamber 7, each reaction tube 15 and each control valve are respectively arranged on the base layer 1. Now refer to Figure 4 The cover layer 16 is provided with an observation window 17 for observing the reaction tube 15 and a shielding area outside the observation window 17 , and the observation window 17 corresponds to the area of ​​the cover layer 16 above the reaction tube 15 .

[0049] Optionally, the base layer 1 and the cover layer 16 are connected by adhesion.

[0050] See now Figure 2 and Figure 4 Specifically, the cover layer 16 is provided with a liquid adding hole 19, a nucleic acid adding hole 20 and a primer hole 9. The position of the liquid adding hole 19 corresponds to the position of the liquid adding chamber 2 and leads to the liquid adding chamber 2. The position of the nucleic acid adding hole 20 corresponds to the position of the nucleic acid adding chamber 3 and leads to the nucleic acid adding chamber 3. The position of each primer chamber 7 is correspondingly provided with a primer hole 9, and the primer hole 9 leads to the corresponding primer chamber 7.

[0051] Specifically, the base layer 1 and the cover layer 16 are made of silicon, glass and polymer materials. The polymer material is polystyrene, polycarbonate, polyvinyl chloride, cycloolefin copolymer, polymethyl methacrylate or polydimethylsiloxane, preferably polydimethylsiloxane.

[0052] Specifically, a light-proof film is attached to the surface of the shielding area.

[0053] Optionally, each primer cavity 7 is provided with freeze-dried primer powder.

[0054] In the present application, each control valve may be a rotary valve. The rotary valve is configured to rotate to change the valve opening, thereby regulating the flow of liquid. The rotary valve is prior art and is therefore not described in detail in the present application.

[0055] Specifically, it includes a fluid driving system for driving the fluid to flow in the device, and the fluid driving system may be a pump system connected to the third upstream control valve 13 - 6 .

[0056] The multi-pathogen nucleic acid detection device provided in the fifth embodiment of the present application is used to perform nucleic acid detection. Before the detection, each control valve is in a closed state. The specific implementation process is as follows:

[0057] (1) Use the FTA blood collection card 18 to collect the blood sample to be tested and dry it thoroughly; take out the FTA blood collection card 18 from the packaging bag, and after taking it out, place the FTA blood collection card 18 in a centrifuge tube and wash it with water for 3 times. The centrifuge tube is independent of the device of the present application; remove the water, add sterile water, heat to 95°C, keep warm for 30 minutes, shake the centrifuge tube several times, preferably shake the centrifuge tube 6 to 8 times. Centrifuge at 3000r / min for 5 minutes to precipitate the macromolecular substances, remove impurities, and absorb the supernatant of the DNA eluate for use.

[0058] (2) Add the DNA eluent into the nucleic acid loading chamber 3.

[0059] (3) Prepare the reaction liquid in the liquid adding chamber 2; after preparation, close the first downstream control valve 13-3 adjacent to the rear end of the mixing chamber 4, open the first upstream control valve 13-1 corresponding to the liquid adding chamber 2 and the nucleic acid adding chamber 3, respectively, so that the reaction liquid and the DNA eluent enter the mixing chamber 4 in a side-by-side manner and are mixed in the mixing chamber 4; the optional mixing method includes gently shaking the detection device back and forth 3-5 times to achieve the mixing effect. Close the first upstream control valve 13-1 before shaking the detection device.

[0060] (4) Open the first downstream control valve 13 - 3 downstream of the mixing chamber 4 and the second upstream control valve 13 - 4 near the reaction tube 15 to distribute the mixed reaction liquid in the mixing chamber 4 to each reaction tube 15 in turn.

[0061] (5) Add the primer into the corresponding primer chamber 7, open the second downstream control valve 13-5 at the far end of the reaction tube 15, and allow the primer to mix with the mixed reaction solution and react to obtain a reaction product. After the mixed reaction solution and the primer flow into each reaction tube 15, close the second downstream control valve 13-5 and the second upstream control valve 13-4 at both ends of each reaction tube 15.

[0062] (6) Open the third upstream control valve 13-6 at the front end of the waste liquid collection chamber 6 to collect excess liquid in the liquid flow tube 14. When no more liquid flows out, close the third upstream control valve 13-6.

[0063] (7) Open the water bath, place the multi-pathogen nucleic acid detection device into the floating plate, embed the device cover layer, and then place it horizontally into the water bath to ensure that the reaction tube is completely placed in the water. Set the amplification temperature to 65°C, the duration to 60 minutes, and terminate at 80°C for 10 minutes.

[0064] (8) After 70 minutes, take out the multi-pathogen nucleic acid detection device and invert it for 30 seconds to 1 minute to dissolve the OTG dye. After observing the color change, invert it back to the normal state. Observe the color indication in each reaction tube 15 through the observation window 17 to quickly judge the experimental results.

[0065] OTG dye can form bright green visible light with the reaction product, which is used to judge the positive or negative of the sample. The standard for judging the positive or negative of the sample is: when the reaction product in the reaction tube 15 changes from orange to green, the amplification reaction is positive; if the color of the reaction product remains orange, the amplification reaction is negative. In addition, it can also be observed under ultraviolet light, the positive reaction tube emits green fluorescence, and the negative reaction tube does not emit fluorescence.

[0066] The utility model provides a concept and method for a multi-pathogen nucleic acid detection device. There are many methods and ways to implement the technical solution. The above is only a preferred implementation of the utility model. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the utility model. These improvements and modifications should also be regarded as the protection scope of the utility model. All components not specified in this embodiment can be implemented using existing technologies.

Claims

1. A multi-pathogen nucleic acid detection device, characterized in that: The detection device comprises: A liquid flow pipeline (14), wherein the liquid flow pipeline (14) is used to receive a mixed reaction solution of a reaction solution and a DNA eluent; and more than one reaction unit, each of the reaction units comprises a reaction tube (15) and a primer chamber (7), the primer chamber (7) being used to introduce a corresponding primer, one end of the reaction tube (15) being selectively connected to the primer chamber (7) in an on-off manner so as to receive the corresponding primer from the primer chamber (7) when connected, and the other end of the reaction tube (15) being selectively connected to the liquid flow conduit (14) in an on-off manner so as to receive the mixed reaction liquid from the liquid flow conduit (14) when connected.

2. A multi-pathogen nucleic acid detection device according to claim 1, characterized in that: The detection device further comprises a liquid adding chamber (2), a nucleic acid adding chamber (3) and a mixing chamber (4); the liquid adding chamber (2) is used to contain a reaction liquid; the nucleic acid adding chamber (3) is used to contain a DNA eluent; the liquid adding chamber (2) and the nucleic acid adding chamber (3) are respectively connectable to the inlet side of the mixing chamber (4), and the liquid flow pipe (14) is connectable to the outlet side of the mixing chamber (4); the mixing chamber (4) is configured to mix the reaction liquid and the DNA eluent, and to provide the mixed reaction liquid to the liquid flow pipe (14).

3. A multi-pathogen nucleic acid detection device according to claim 2, characterized in that: The detection device also includes an OTG dye and a light-transmitting area (5), wherein the OTG dye is pre-placed at the top of the inner cavity of the reaction tube (15), the light-transmitting area (5) corresponds to the area where the reaction tube (15) is located, and the light-transmitting area (5) is configured to allow ultraviolet light to pass through.

4. A multi-pathogen nucleic acid detection device according to claim 3, characterized in that: The invention also comprises a waste liquid collection chamber (6) and a liquid discharge port (8); the waste liquid collection chamber (6) can be selectively connected to the liquid flow pipe (14) in an on-off manner, and is used to collect more mixed reaction liquid than the reaction tube (15) when connected; the liquid discharge port (8) can be selectively connected to the waste liquid collection chamber (6) in an on-off manner, and is used to discharge the liquid in the waste liquid collection chamber (6) when connected.

5. A multi-pathogen nucleic acid detection device according to claim 4, characterized in that: It comprises a second upstream control valve (13-4) and a second downstream control valve (13-5), one end of the reaction tube (15) is connected to the primer chamber (7) through the second downstream control valve (13-5), and the other end of the reaction tube (15) is connected to the liquid flow pipeline (14) through the second upstream control valve (13-4).

6. A multi-pathogen nucleic acid detection device according to claim 5, characterized in that: The invention comprises a sample loading microfluidic channel (12), a first upstream control valve (13-1) and a first downstream control valve (13-3); the liquid loading chamber (2) and the nucleic acid loading chamber (3) are respectively connected to the inlet side fluid of the mixing chamber (4) through a corresponding sample loading microfluidic channel (12); each sample loading microfluidic channel (12) is respectively provided with a first upstream control valve (13-1), and the first upstream control valve (13-1) is configured to control the on-off of the sample loading microfluidic channel (12) where it is located; the first downstream control valve (13-3) is configured to selectively cut off the flow of the fluid in the mixing chamber (4) to the liquid flow pipeline (14).

7. A multi-pathogen nucleic acid detection device according to claim 6, characterized in that: It comprises a third upstream control valve (13-6) and a third downstream control valve (13-7), the waste liquid collection chamber (6) is connected to the liquid flow pipeline (14) through the third upstream control valve (13-6), and the discharge port (8) is connected to the waste liquid collection chamber (6) through the third downstream control valve (13-7).

8. A multi-pathogen nucleic acid detection device according to claim 4, characterized in that: The detection device has a split structure and comprises a base layer (1) and a cover layer (16) covering the upper side of the base layer (1); the liquid adding chamber (2), the nucleic acid adding chamber (3), the mixing chamber (4), the liquid flow pipeline (14), each primer chamber (7), each reaction tube (15) and each control valve are respectively arranged on the base layer.

9. A multi-pathogen nucleic acid detection device according to claim 8, characterized in that: The cover plate layer (16) is provided with an observation window (17) for observing the reaction tube (15) and a shielding area outside the observation window (17), and the observation window (17) corresponds to the area of ​​the cover plate layer (16) above the reaction tube (15).

10. A multi-pathogen nucleic acid detection device according to claim 9, characterized in that: The cover layer (16) is provided with a liquid adding hole (19), a nucleic acid adding hole (20) and a primer hole (9); the position of the liquid adding hole (19) corresponds to the position of the liquid adding chamber (2) and leads to the liquid adding chamber (2); the position of the nucleic acid adding hole (20) corresponds to the position of the nucleic acid adding chamber (3) and leads to the nucleic acid adding chamber (3); and a primer hole (9) is provided corresponding to the position of each primer chamber (7), and the primer hole (9) leads to the corresponding primer chamber (7).